Restoration of enzymatic activity in a Ser-49 phospholipase A2 homologue decreases its Ca(2+)-independent membrane-damaging activity and increases its toxicity

Ammodytin L (AtnL) is a Ser-49 secretory phospholipase A2 (sPLA2) homologue with myotoxic activity. By analogy to the Lys-49 sPLA2 myotoxins, AtnL has been predicted to be enzymatically inactive due to the absence of the conserved Asp-49 that participates in coordination of the Ca2+ cofactor. By sub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 2007-11, Vol.46 (44), p.12795
Hauptverfasser: Petan, Toni, Krizaj, Igor, Pungercar, Joze
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 44
container_start_page 12795
container_title Biochemistry (Easton)
container_volume 46
creator Petan, Toni
Krizaj, Igor
Pungercar, Joze
description Ammodytin L (AtnL) is a Ser-49 secretory phospholipase A2 (sPLA2) homologue with myotoxic activity. By analogy to the Lys-49 sPLA2 myotoxins, AtnL has been predicted to be enzymatically inactive due to the absence of the conserved Asp-49 that participates in coordination of the Ca2+ cofactor. By substituting Ser-49 and three other residues in the Ca2+-binding loop of AtnL, we obtained the first two enzymatically active mutants of Lys-49/Ser-49 sPLA2 homologues. The mutants LW and LV, which differed only by the presence of Trp and Val at position 31, respectively, efficiently hydrolyzed phospholipid vesicles, while recombinant AtnL displayed no activity. In contrast to AtnL but similarly to ammodytoxin A (AtxA), a homologous neurotoxic sPLA2, both mutants exhibited catalysis-dependent membrane-damaging ability, involving vesicle contents leakage and fusion. However, LW and LV also exhibited the potent, Ca2+-independent disruption of vesicle integrity characteristic of AtnL, but not of AtxA, in which leakage of the contents is not associated with membrane fusion. Although LV and, especially, LW have the advantage over AtnL of being able to act in both Ca2+-independent and Ca2+-dependent modes, and display higher cytotoxicity and higher lethal potency, they have a lower Ca2+-independent membrane-damaging potency and display reduced specificity in targeting muscle fibers in vitro. Our results indicate that, in evolution, Lys-49 and Ser-49 sPLA2 myotoxins have lost their Ca2+-binding ability and enzymatic activity through subtle changes in the Ca2+-binding network without affecting the rest of the catalytic machinery, thereby optimizing their Ca2+-independent membrane-damaging ability and myotoxic activity.
doi_str_mv 10.1021/bi701304e
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_17927217</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17927217</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-2177f1fd1d85db2deb00ba7b47a6c65dfb936845d06bd6daeeb3d75549d1384a3</originalsourceid><addsrcrecordid>eNpNUE1LAzEQzUGxtXrwD0iOiqwm2eymeyzFLygIfpzLZDPbRppk2aRi_TP-VQMqepg3vDfMe8wQcsLZJWeCX2mrGC-ZxD0yZozVhWhqNiKHMb5mKpmSB2TEVSOU4GpMPh8xpjBAssHT0FH0HzuXWUuhTfbNph21ngJ9wqGQDe3XIeba2B4i0pmg6-DCJqy2SA22A2Y1UpsincOZuDgvrDfYYwafqEOnB_BYGHCwsn71FwHe5Jj_-ym82zaPjsh-B5uIxz99Ql5urp_nd8Xi4fZ-PlsUPRcyFfkW1fHOcDOtjBYGNWMalJYK6rauTKebsp7KyrBam9oAoi6NqirZGF5OJZQTcvrt22-1Q7PsB-tg2C1_P1V-AVyva7s</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Restoration of enzymatic activity in a Ser-49 phospholipase A2 homologue decreases its Ca(2+)-independent membrane-damaging activity and increases its toxicity</title><source>MEDLINE</source><source>ACS Publications</source><creator>Petan, Toni ; Krizaj, Igor ; Pungercar, Joze</creator><creatorcontrib>Petan, Toni ; Krizaj, Igor ; Pungercar, Joze</creatorcontrib><description>Ammodytin L (AtnL) is a Ser-49 secretory phospholipase A2 (sPLA2) homologue with myotoxic activity. By analogy to the Lys-49 sPLA2 myotoxins, AtnL has been predicted to be enzymatically inactive due to the absence of the conserved Asp-49 that participates in coordination of the Ca2+ cofactor. By substituting Ser-49 and three other residues in the Ca2+-binding loop of AtnL, we obtained the first two enzymatically active mutants of Lys-49/Ser-49 sPLA2 homologues. The mutants LW and LV, which differed only by the presence of Trp and Val at position 31, respectively, efficiently hydrolyzed phospholipid vesicles, while recombinant AtnL displayed no activity. In contrast to AtnL but similarly to ammodytoxin A (AtxA), a homologous neurotoxic sPLA2, both mutants exhibited catalysis-dependent membrane-damaging ability, involving vesicle contents leakage and fusion. However, LW and LV also exhibited the potent, Ca2+-independent disruption of vesicle integrity characteristic of AtnL, but not of AtxA, in which leakage of the contents is not associated with membrane fusion. Although LV and, especially, LW have the advantage over AtnL of being able to act in both Ca2+-independent and Ca2+-dependent modes, and display higher cytotoxicity and higher lethal potency, they have a lower Ca2+-independent membrane-damaging potency and display reduced specificity in targeting muscle fibers in vitro. Our results indicate that, in evolution, Lys-49 and Ser-49 sPLA2 myotoxins have lost their Ca2+-binding ability and enzymatic activity through subtle changes in the Ca2+-binding network without affecting the rest of the catalytic machinery, thereby optimizing their Ca2+-independent membrane-damaging ability and myotoxic activity.</description><identifier>ISSN: 0006-2960</identifier><identifier>DOI: 10.1021/bi701304e</identifier><identifier>PMID: 17927217</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Calcium - pharmacology ; Cell Membrane - drug effects ; Cells, Cultured ; Cytotoxins - metabolism ; Cytotoxins - pharmacology ; Enzyme Activation - drug effects ; Fluoresceins - pharmacology ; Mice ; Mutant Proteins - metabolism ; Mutant Proteins - pharmacology ; Phospholipases A2, Secretory - genetics ; Phospholipases A2, Secretory - metabolism ; Phospholipases A2, Secretory - pharmacology ; Phospholipids - chemistry ; Protein Engineering ; Protein Structure, Secondary ; Sequence Homology, Amino Acid ; Serine - genetics ; Unilamellar Liposomes - chemistry ; Viper Venoms - genetics ; Viper Venoms - metabolism ; Viper Venoms - pharmacology</subject><ispartof>Biochemistry (Easton), 2007-11, Vol.46 (44), p.12795</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17927217$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Petan, Toni</creatorcontrib><creatorcontrib>Krizaj, Igor</creatorcontrib><creatorcontrib>Pungercar, Joze</creatorcontrib><title>Restoration of enzymatic activity in a Ser-49 phospholipase A2 homologue decreases its Ca(2+)-independent membrane-damaging activity and increases its toxicity</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>Ammodytin L (AtnL) is a Ser-49 secretory phospholipase A2 (sPLA2) homologue with myotoxic activity. By analogy to the Lys-49 sPLA2 myotoxins, AtnL has been predicted to be enzymatically inactive due to the absence of the conserved Asp-49 that participates in coordination of the Ca2+ cofactor. By substituting Ser-49 and three other residues in the Ca2+-binding loop of AtnL, we obtained the first two enzymatically active mutants of Lys-49/Ser-49 sPLA2 homologues. The mutants LW and LV, which differed only by the presence of Trp and Val at position 31, respectively, efficiently hydrolyzed phospholipid vesicles, while recombinant AtnL displayed no activity. In contrast to AtnL but similarly to ammodytoxin A (AtxA), a homologous neurotoxic sPLA2, both mutants exhibited catalysis-dependent membrane-damaging ability, involving vesicle contents leakage and fusion. However, LW and LV also exhibited the potent, Ca2+-independent disruption of vesicle integrity characteristic of AtnL, but not of AtxA, in which leakage of the contents is not associated with membrane fusion. Although LV and, especially, LW have the advantage over AtnL of being able to act in both Ca2+-independent and Ca2+-dependent modes, and display higher cytotoxicity and higher lethal potency, they have a lower Ca2+-independent membrane-damaging potency and display reduced specificity in targeting muscle fibers in vitro. Our results indicate that, in evolution, Lys-49 and Ser-49 sPLA2 myotoxins have lost their Ca2+-binding ability and enzymatic activity through subtle changes in the Ca2+-binding network without affecting the rest of the catalytic machinery, thereby optimizing their Ca2+-independent membrane-damaging ability and myotoxic activity.</description><subject>Animals</subject><subject>Calcium - pharmacology</subject><subject>Cell Membrane - drug effects</subject><subject>Cells, Cultured</subject><subject>Cytotoxins - metabolism</subject><subject>Cytotoxins - pharmacology</subject><subject>Enzyme Activation - drug effects</subject><subject>Fluoresceins - pharmacology</subject><subject>Mice</subject><subject>Mutant Proteins - metabolism</subject><subject>Mutant Proteins - pharmacology</subject><subject>Phospholipases A2, Secretory - genetics</subject><subject>Phospholipases A2, Secretory - metabolism</subject><subject>Phospholipases A2, Secretory - pharmacology</subject><subject>Phospholipids - chemistry</subject><subject>Protein Engineering</subject><subject>Protein Structure, Secondary</subject><subject>Sequence Homology, Amino Acid</subject><subject>Serine - genetics</subject><subject>Unilamellar Liposomes - chemistry</subject><subject>Viper Venoms - genetics</subject><subject>Viper Venoms - metabolism</subject><subject>Viper Venoms - pharmacology</subject><issn>0006-2960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNUE1LAzEQzUGxtXrwD0iOiqwm2eymeyzFLygIfpzLZDPbRppk2aRi_TP-VQMqepg3vDfMe8wQcsLZJWeCX2mrGC-ZxD0yZozVhWhqNiKHMb5mKpmSB2TEVSOU4GpMPh8xpjBAssHT0FH0HzuXWUuhTfbNph21ngJ9wqGQDe3XIeba2B4i0pmg6-DCJqy2SA22A2Y1UpsincOZuDgvrDfYYwafqEOnB_BYGHCwsn71FwHe5Jj_-ym82zaPjsh-B5uIxz99Ql5urp_nd8Xi4fZ-PlsUPRcyFfkW1fHOcDOtjBYGNWMalJYK6rauTKebsp7KyrBam9oAoi6NqirZGF5OJZQTcvrt22-1Q7PsB-tg2C1_P1V-AVyva7s</recordid><startdate>20071106</startdate><enddate>20071106</enddate><creator>Petan, Toni</creator><creator>Krizaj, Igor</creator><creator>Pungercar, Joze</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20071106</creationdate><title>Restoration of enzymatic activity in a Ser-49 phospholipase A2 homologue decreases its Ca(2+)-independent membrane-damaging activity and increases its toxicity</title><author>Petan, Toni ; Krizaj, Igor ; Pungercar, Joze</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-2177f1fd1d85db2deb00ba7b47a6c65dfb936845d06bd6daeeb3d75549d1384a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Calcium - pharmacology</topic><topic>Cell Membrane - drug effects</topic><topic>Cells, Cultured</topic><topic>Cytotoxins - metabolism</topic><topic>Cytotoxins - pharmacology</topic><topic>Enzyme Activation - drug effects</topic><topic>Fluoresceins - pharmacology</topic><topic>Mice</topic><topic>Mutant Proteins - metabolism</topic><topic>Mutant Proteins - pharmacology</topic><topic>Phospholipases A2, Secretory - genetics</topic><topic>Phospholipases A2, Secretory - metabolism</topic><topic>Phospholipases A2, Secretory - pharmacology</topic><topic>Phospholipids - chemistry</topic><topic>Protein Engineering</topic><topic>Protein Structure, Secondary</topic><topic>Sequence Homology, Amino Acid</topic><topic>Serine - genetics</topic><topic>Unilamellar Liposomes - chemistry</topic><topic>Viper Venoms - genetics</topic><topic>Viper Venoms - metabolism</topic><topic>Viper Venoms - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Petan, Toni</creatorcontrib><creatorcontrib>Krizaj, Igor</creatorcontrib><creatorcontrib>Pungercar, Joze</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petan, Toni</au><au>Krizaj, Igor</au><au>Pungercar, Joze</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Restoration of enzymatic activity in a Ser-49 phospholipase A2 homologue decreases its Ca(2+)-independent membrane-damaging activity and increases its toxicity</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2007-11-06</date><risdate>2007</risdate><volume>46</volume><issue>44</issue><spage>12795</spage><pages>12795-</pages><issn>0006-2960</issn><abstract>Ammodytin L (AtnL) is a Ser-49 secretory phospholipase A2 (sPLA2) homologue with myotoxic activity. By analogy to the Lys-49 sPLA2 myotoxins, AtnL has been predicted to be enzymatically inactive due to the absence of the conserved Asp-49 that participates in coordination of the Ca2+ cofactor. By substituting Ser-49 and three other residues in the Ca2+-binding loop of AtnL, we obtained the first two enzymatically active mutants of Lys-49/Ser-49 sPLA2 homologues. The mutants LW and LV, which differed only by the presence of Trp and Val at position 31, respectively, efficiently hydrolyzed phospholipid vesicles, while recombinant AtnL displayed no activity. In contrast to AtnL but similarly to ammodytoxin A (AtxA), a homologous neurotoxic sPLA2, both mutants exhibited catalysis-dependent membrane-damaging ability, involving vesicle contents leakage and fusion. However, LW and LV also exhibited the potent, Ca2+-independent disruption of vesicle integrity characteristic of AtnL, but not of AtxA, in which leakage of the contents is not associated with membrane fusion. Although LV and, especially, LW have the advantage over AtnL of being able to act in both Ca2+-independent and Ca2+-dependent modes, and display higher cytotoxicity and higher lethal potency, they have a lower Ca2+-independent membrane-damaging potency and display reduced specificity in targeting muscle fibers in vitro. Our results indicate that, in evolution, Lys-49 and Ser-49 sPLA2 myotoxins have lost their Ca2+-binding ability and enzymatic activity through subtle changes in the Ca2+-binding network without affecting the rest of the catalytic machinery, thereby optimizing their Ca2+-independent membrane-damaging ability and myotoxic activity.</abstract><cop>United States</cop><pmid>17927217</pmid><doi>10.1021/bi701304e</doi></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 2007-11, Vol.46 (44), p.12795
issn 0006-2960
language eng
recordid cdi_pubmed_primary_17927217
source MEDLINE; ACS Publications
subjects Animals
Calcium - pharmacology
Cell Membrane - drug effects
Cells, Cultured
Cytotoxins - metabolism
Cytotoxins - pharmacology
Enzyme Activation - drug effects
Fluoresceins - pharmacology
Mice
Mutant Proteins - metabolism
Mutant Proteins - pharmacology
Phospholipases A2, Secretory - genetics
Phospholipases A2, Secretory - metabolism
Phospholipases A2, Secretory - pharmacology
Phospholipids - chemistry
Protein Engineering
Protein Structure, Secondary
Sequence Homology, Amino Acid
Serine - genetics
Unilamellar Liposomes - chemistry
Viper Venoms - genetics
Viper Venoms - metabolism
Viper Venoms - pharmacology
title Restoration of enzymatic activity in a Ser-49 phospholipase A2 homologue decreases its Ca(2+)-independent membrane-damaging activity and increases its toxicity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T21%3A44%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Restoration%20of%20enzymatic%20activity%20in%20a%20Ser-49%20phospholipase%20A2%20homologue%20decreases%20its%20Ca(2+)-independent%20membrane-damaging%20activity%20and%20increases%20its%20toxicity&rft.jtitle=Biochemistry%20(Easton)&rft.au=Petan,%20Toni&rft.date=2007-11-06&rft.volume=46&rft.issue=44&rft.spage=12795&rft.pages=12795-&rft.issn=0006-2960&rft_id=info:doi/10.1021/bi701304e&rft_dat=%3Cpubmed%3E17927217%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17927217&rfr_iscdi=true